Type 2 diabetes mellitus is characterized by reduced postprandial adiponectin response: a possible link with diabetic postprandial dyslipidemia

Metabolism: Clinical and Experimental

Volumn 59, Issue 4, 2010, Pages 567-574

  Annuzzi, Giovanni ^a   Bozzetto, Lutgarda ^a   Patti, Lidia ^a   Santangelo, Carmela ^b   Giacco, Rosalba ^c   Di Marino, Lucrezia ^a   De Natale, Claudia ^a   Masella, Roberta ^b   Riccardi, Gabriele ^a   Rivellese, Angela A ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^c CNR   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; CHOLESTEROL; CHYLOMICRON; GLUCOSE; INSULIN; LIPID; LIPOPROTEIN LIPASE; LOW DENSITY LIPOPROTEIN; MESSENGER RNA; TRIACYLGLYCEROL;

ADIPOSE TISSUE; ADULT; ARTICLE; BLOOD SAMPLING; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; DYSLIPIDEMIA; GENE EXPRESSION; HUMAN; INSULIN RESISTANCE; LIPOPROTEIN METABOLISM; MALE; NEEDLE BIOPSY; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEOTIDE SEQUENCE; OBESITY; POSTPRANDIAL STATE; PRIORITY JOURNAL; WAIST CIRCUMFERENCE;

ADIPONECTIN; ADIPOSE TISSUE; ADULT; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DYSLIPIDEMIAS; FEMALE; HUMANS; INSULIN; LIPOPROTEIN LIPASE; MALE; MIDDLE AGED; POSTPRANDIAL PERIOD;

EID: 77949450527     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2009.08.020     Document Type: Article

References (39)

1. Havel P.J. Update on adipocyte hormones: regulation of energy balance and carbohydrate/lipid metabolism. Diabetes 53 Suppl 1 (2004) S143-S151
2. Kantartzis K., Fritsche A., Tschritter O., et al. The association between plasma adiponectin and insulin sensitivity in humans depends on obesity. Obes Res 13 (2005) 1683-1691
3. Kadowaki T., Yamauchi T., Kubota N., et al. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest 116 (2006) 1784-1792
4. Yatagai T., Nagasaka S., Taniguchi A., et al. Hypoadiponectinemia is associated with visceral fat accumulation and insulin resistance in Japanese men with type 2 diabetes mellitus. Metabolism 52 (2003) 1274-1278
5. Duncan B.B., Schmidt M.I., Pankow J.S., et al. Adiponectin and the development of type 2 diabetes: the atherosclerosis risk in communities study. Diabetes 53 (2004) 2473-2478
6. Kumada M., Kihara S., Sumitsuji S., et al. Association of hypoadiponectinemia with coronary artery disease in men. Arterioscler Thromb Vasc Biol 23 (2003) 85-89
7. Han S.H., Quon M.J., Kim J.A., et al. Adiponectin and cardiovascular disease: response to therapeutic interventions. J Am Coll Cardiol 49 (2007) 531-538
8. Karpe F. Postprandial lipoprotein metabolism and atherosclerosis. J Int Med 246 (1999) 341-355
9. Ceriello A., Hanefeld M., Leiter L., et al. Postprandial glucose regulation and diabetic complications. Arch Intern Med 164 (2004) 2090-2095
10. English P.J., Coughlin S.R., and Hayden K. Plasma adiponectin increases postprandially in obese, but not in lean, subjects. Obes Res 11 (2003) 839-844
11. Karlsson F.A., Engstrom B.E., and Lind L. No postprandial increase of plasma adiponectin in obese subjects. Obes Res 12 (2004) 1031-1032
12. English P.J., Coughlin S.R., and Hayden K. Response: postprandial adiponectin revisited. Obes Res 12 (2004) 1032-1034
13. Frayn K.N. Adipose tissue as a buffer for daily lipid flux. Diabetologia 45 (2002) 1201-1210
14. Annuzzi G., De Natale C., Iovine C., et al. Insulin resistance is independently associated with postprandial alterations of triglyceride-rich lipoproteins in type 2 diabetes mellitus. Arterioscler Thromb Vasc Biol 24 (2004) 2397-2402
15. Rivellese A.A., De Natale C., Di Marino L., et al. Exogenous and endogenous postprandial lipid abnormalities in type 2 diabetic patients with optimal blood glucose control and optimal fasting triglyceride levels. J Clin Endocrinol Metab 89 (2004) 2153-2159
16. von Eynatten M., Schneider J.G., Humpert P.M., et al. Decreased plasma lipoprotein lipase in hypoadiponectinemia: an association independent of systemic inflammation and insulin resistance. Diabetes Care 27 (2004) 2925-2929
17. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report on the diagnosis and classification of diabetes mellitus. Diabetes Care Supp. 1 (2003) S5-S20
18. DeFronzo R.A., Tobin J.D., and Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237 (1979) E214-E223
19. Rivellese A.A., Giacco R., Annuzzi G., et al. Effects of monounsaturated vs. saturated fat on postprandial lipemia and adipose tissue lipases in type 2 diabetes. Clin Nutr 27 (2008) 133-141
20. Lupi R., Dotta F., Marselli L., et al. Prolonged exposure to free fatty acids has cytostatic and caspase-mediated, pro-apoptotic effects on human pancreatic beta-cells. Diabetes 1 (2002) 1437-1442
21. Santangelo C., Matarrese P., Masella R., et al. Hepatocyte growth factor protects rat RINm5F cell line against free fatty acid-induced apoptosis by counteracting oxidative stress. J Mol Endocrinol 38 (2007) 147-158
22. Behre C.J., Gummesson A., Jernås M., et al. Dissociation between adipose tissue expression and serum levels of adiponectin during and after diet-induced weight loss in obese subjects with and without the metabolic syndrome. Metabolism 56 (2007) 1022-1028
23. Peake P.W., Kriketos A.D., Denyer G.S., et al. The postprandial response of adiponectin to a high-fat meal in normal and insulin-resistant subjects. Int J Obes Relat Metab Disord 27 (2003) 657-662
24. Musso G., Gambino R., Durazzo M., et al. Adipokines in NASH: postprandial lipid metabolism as a link between adiponectin and liver disease. Hepatology 42 (2005) 1175-1183
25. Esposito K., Nappo F., Giugliano F., et al. Meal modulation of circulating interleukin 18 and adiponectin concentrations in healthy subjects and in patients with type 2 diabetes mellitus. Am J Clin Nutr 78 (2003) 1135-1140
26. Bueno A.A., Oyama L.M., de Oliveira C., et al. Effects of different fatty acids and dietary lipids on adiponectin gene expression in 3T3-L1 cells and C57BL/6J mice adipose tissue. Pflugers Arch 455 (2008) 701-709
27. Pawlak D.B., Kushner J.A., and Ludwig D.S. Effects of dietary glycaemic index on adiposity, glucose homoeostasis, and plasma lipids in animals. Lancet 364 (2004) 778-785
28. Tacke F., Wustefeld T., Horn R., et al. Hepatic high adiponectin in chronic liver disease and cholestasis suggests biliary route of adiponectin excretion in vivo. J Hepatol 42 (2005) 666-673
29. Yaturu S., Reddy R.D., Rains J., et al. Plasma and urine levels of resistin and adiponectin in chronic kidney disease. Cytokine 37 (2007) 1-5
30. Weyer C., Funahashi T., Tanaka S., et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 86 (2001) 1930-1935
31. Bogan J.S., and Lodish H.F. Two compartments for insulin-stimulated exocytosis in 3T3-L1 adipocytes defined by endogenous ACRP30 and GLUT4. J Cell Biol 146 (1999) 609-620
32. Motoshima H., Wu X., Sinha M.K., et al. Differential regulation of adiponectin secretion from cultured human omental and subcutaneous adipocytes: effects of insulin and rosiglitazone. J Clin Endocrinol Metab 87 (2002) 5662-5667
33. Halleux C.M., Takahashi M., Delporte M.L., et al. Secretion of adiponectin and regulation of apM1 gene expression in human visceral adipose tissue. Biochem Biophys Res Commun 288 (2001) 1102-1107
34. Pereira R.I., and Draznin B. Inhibition of the phosphatidylinositol 3'-kinase signaling pathway leads to decreased insulin-stimulated adiponectin secretion from 3T3-L1 adipocytes. Metabolism 54 (2005) 1636-1643
35. Semple R.K., Halberg N.H., Burling K., et al. Paradoxical elevation of high-molecular weight adiponectin in acquired extreme insulin resistance due to insulin receptor antibodies. Diabetes 56 (2007) 1712-1717
36. Semple R.K., Soos M.A., Luan J., et al. Elevated plasma adiponectin in humans with genetically defective insulin receptors. J Clin Endocrinol Metab 91 (2006) 3219-3223
37. Fasshauer M., Klein J., Neumann S., et al. Hormonal regulation of adiponectin gene expression in 3T3-L1 adipocytes. Biochem Biophys Res Commun 290 (2002) 1084-1089
38. Zietz B., Herfarth H., Paul G., et al. Adiponectin represents an independent cardiovascular risk factor predicting serum HDL-cholesterol levels in type 2 diabetes. FEBS Lett 545 (2003) 103-104
39. Schneider J.G., von Eynatten M., Schiekofer S., et al. Low plasma adiponectin levels are associated with increased hepatic lipase activity in vivo. Diabetes Care 28 (2005) 2181-2186